In a 35-year-old female with end-stage renal disease on thrice-weekly hemodialysis, type 2 diabetes mellitus, severe peripheral vascular disease, legal blindness, bilateral toe amputations, and a non-healing left foot ulcer with constant 10/10 burning pain (currently on ciprofloxacin after dialysis and requesting home-health skilled nursing), who now presents with acute right calf pain that worsens with standing and ambulation, is tender to touch, and raises concern for deep‑vein thrombosis, what is the appropriate urgent evaluation and management plan?

Immediate Emergency Department Referral for Suspected DVT with Urgent Complete Duplex Ultrasound

This patient requires immediate emergency department evaluation for suspected deep vein thrombosis (DVT) given her acute right calf pain, tenderness, and extremely high-risk profile—she should not delay this assessment.

Clinical Risk Stratification

Using the Wells score for DVT pretest probability 1:

• Active cancer or recent major surgery: 0 (not applicable)
• Bedridden ≥3 days: 0
• Localized tenderness along deep venous system: +1
• Entire leg swollen: 0 (calf only)
• Calf swelling ≥3 cm vs. contralateral: Unknown, but likely +1
• Pitting edema confined to symptomatic leg: likely +1
• Collateral superficial veins: 0
• Previously documented DVT: 0
• Alternative diagnosis as likely: 0 (infected wounds are bilateral, new unilateral calf pain is distinct)

Estimated Wells score: ≥2 = "DVT likely" — this bypasses D-dimer testing and mandates immediate imaging 1.

Urgent Diagnostic Evaluation

Complete duplex ultrasound (CDUS) is the required diagnostic test 1. This must include:

• Compression of deep veins from inguinal ligament to ankle at 2-cm intervals
• Bilateral common femoral vein spectral Doppler waveforms
• Popliteal spectral Doppler
• Color Doppler imaging
• Mandatory evaluation of calf veins (posterior tibial and peroneal veins) 1

Critical point: Limited protocols that exclude calf veins are explicitly not recommended because they require repeat scanning in 5-7 days and risk missing isolated calf DVT that can propagate proximally 1. Given this patient's ESRD, immobility risk, and infected wounds, calf vein evaluation is essential.

If the initial ultrasound is negative but symptoms persist or worsen, repeat CDUS at 5-7 days or earlier is mandated 1.

Anticoagulation Considerations in ESRD

If DVT is confirmed, anticoagulation management is exceptionally complex in this patient:

Unfractionated heparin (UFH) is the preferred agent in ESRD due to its short half-life, lack of renal clearance, and adjustability via aPTT monitoring 2. This is critical given her thrice-weekly hemodialysis.

Low-molecular-weight heparins require dose reduction in CKD stage 5/ESRD due to reduced clearance and accumulation risk 2.

Warfarin can be used but requires meticulous INR monitoring (target ≤4) to minimize bleeding risk, which is already elevated in ESRD 2.

Apixaban is the only DOAC with evidence supporting use in patients with eGFR <15 mL/min or on dialysis 2, though data remain limited.

Bleeding vs. Thrombosis Risk Balance

This patient faces a paradoxical hemostatic state: ESRD creates both hypercoagulability (platelet dysfunction, altered coagulation factors, vascular endothelial damage) and increased bleeding risk 2. Her active bilateral foot infections with recent amputations substantially elevate bleeding concerns.

If DVT is confirmed, the decision to anticoagulate must weigh:

• Mortality risk from untreated DVT/PE (potentially fatal)
• Bleeding risk from infected surgical sites (potentially limb-threatening)
• Quality of life: Further amputation vs. PE-related disability

In this specific context, if DVT is confirmed, anticoagulation is likely necessary despite bleeding risks, as PE mortality exceeds bleeding complications in most cases. However, this requires urgent vascular surgery and nephrology consultation.

Pain Management Strategy

Her 10/10 burning foot pain suggests neuropathic pain from diabetic peripheral neuropathy superimposed on ischemic rest pain from severe peripheral vascular disease 3, 4.

Immediate pain management should include:

• Gabapentin or pregabalin as first-line for neuropathic pain (dose-adjusted for ESRD: gabapentin 100-300 mg post-dialysis, NOT daily)
• Duloxetine (if not contraindicated) for diabetic neuropathy
• Opioids (short-acting, dose-adjusted for renal function) for breakthrough pain, recognizing accumulation risk in ESRD
• Topical lidocaine to wound periphery (avoiding open areas)

Avoid NSAIDs entirely given ESRD 5.

Infection Management Concerns

Ciprofloxacin once daily after dialysis is appropriate dosing for ESRD 5, as approximately 40-50% is renally excreted and hemodialysis removes <10% 5. However, verify:

• Culture-directed therapy: Ensure ciprofloxacin covers identified organisms
• Osteomyelitis evaluation: Bilateral toe amputations with persistent non-healing suggest possible bone involvement requiring 6+ weeks of therapy
• Wound cultures: If not recently obtained, repeat to guide therapy

Home Health Coordination

Home Health skilled nursing is medically necessary given:

• Legal blindness preventing self-wound care
• Complex wound management requiring sterile technique
• High infection risk with ESRD immunosuppression

Coordination protocol:

• Home Health should perform wound care on non-Wednesday days (avoiding overlap with provider's Wednesday visits)
• Establish clear communication channel between Home Health nurse and wound care provider
• Document wound progression with photography at each visit
• Train family member as backup for emergencies

Vascular Surgery Urgency

Pending vascular surgery referral must be expedited given:

• Severe peripheral vascular disease with non-healing ulcers
• Possible critical limb ischemia (constant 10/10 pain, non-healing wounds)
• Risk of further amputation without revascularization 4

Request urgent (within 1 week) vascular evaluation for:

• Ankle-brachial index (if not recently done)
• Arterial duplex or CT angiography
• Revascularization candidacy assessment
• Limb salvage planning

Common Pitfalls to Avoid

1. Do not delay DVT imaging waiting for D-dimer in a "DVT likely" patient—this wastes time and D-dimer has poor specificity in infection/inflammation 1
2. Do not use standard LMWH dosing in ESRD—accumulation causes life-threatening bleeding 2
3. Do not assume bilateral foot infections explain unilateral new calf pain—these are distinct processes requiring separate evaluation
4. Do not prescribe gabapentin daily in ESRD—it accumulates and causes severe sedation/encephalopathy; dose post-dialysis only
5. Do not defer vascular evaluation until wounds "improve"—non-healing wounds in severe PVD will not improve without revascularization 4

Immediate Action Plan

1. Send patient to ED now for DVT evaluation (do not wait for outpatient ultrasound)
2. ED should obtain complete duplex ultrasound including calf veins
3. If DVT confirmed: Admit for anticoagulation initiation with UFH, nephrology and vascular surgery consultation
4. If DVT excluded: Urgent outpatient vascular surgery referral (within 1 week) for limb salvage evaluation
5. Initiate neuropathic pain regimen today (gabapentin 100 mg post-dialysis, titrate based on response)
6. Expedite Home Health approval with specific coordination instructions
7. Follow up in 3-5 days (or sooner if not admitted) to reassess pain control and confirm specialty appointments

The combination of possible DVT, critical limb ischemia, and uncontrolled pain in an ESRD patient represents a medical emergency requiring same-day evaluation 2, 4.